Brief: Sienna Biopharma Announces Successful Appeal Of Nasdaq Delisting Notice
14/11/2019 14:05
Nov 14 (Reuters) - Sienna Biopharmaceuticals Inc SNNA.O :
* SIENNA BIOPHARMACEUTICALS ANNOUNCES SUCCESSFUL APPEAL OF
NASDAQ
DELISTING NOTICE
* SIENNA BIOPHARMACEUTICALS - STOCK TO REMAIN CONDITIONALLY
LISTED
DURING CHAPTER 11 ASSET SALE PROCESS
* SIENNA BIOPHARMACEUTICALS - CONTINUES TO MANAGE AND
OPERATE
BUSINESS UNDER JURISDICTION OF COURT
Source text for Eikon: ID:nGNX33ByfW
Further company coverage: SNNA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sienna Biopharmaceuticals
See all newsU.S. STOCKS ON THE MOVE-Adobe, Oracle, Snap, Phreesia, Sarepta, Aquestive Therapeutics, Patterson-UTI
U.S. STOCKS ON THE MOVE-Lululemon, GE, Starbucks, Delta Air Lines, Lumber Liquidators, Lovesac
Sienna Biopharma: Falls on Nasdaq delisting plans
Brief: Sienna Biopharma Says Bankruptcy Court Approved Sale Of Assets Related To SNA-001 For $1.7 Mln In Cash
Brief: Sienna Biopharmaceuticals Announces Court Approval Of Chapter 11 Bidding Procedures